DK0531529T3 - Fremgangsmåde til fremstilling af en vandig suspension - Google Patents

Fremgangsmåde til fremstilling af en vandig suspension

Info

Publication number
DK0531529T3
DK0531529T3 DK91912370.3T DK91912370T DK0531529T3 DK 0531529 T3 DK0531529 T3 DK 0531529T3 DK 91912370 T DK91912370 T DK 91912370T DK 0531529 T3 DK0531529 T3 DK 0531529T3
Authority
DK
Denmark
Prior art keywords
preparing
aqueous suspension
pentyloxyphenyl
thiazolidine
ethoxy
Prior art date
Application number
DK91912370.3T
Other languages
English (en)
Inventor
Hisayuki Nakayama
Kazumichi Ushio
Katsuhiro Inada
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0531529T3 publication Critical patent/DK0531529T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
DK91912370.3T 1991-03-27 1991-07-11 Fremgangsmåde til fremstilling af en vandig suspension DK0531529T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6290991 1991-03-27

Publications (1)

Publication Number Publication Date
DK0531529T3 true DK0531529T3 (da) 1997-04-21

Family

ID=13213855

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91912370.3T DK0531529T3 (da) 1991-03-27 1991-07-11 Fremgangsmåde til fremstilling af en vandig suspension

Country Status (14)

Country Link
US (1) US5366985A (da)
EP (1) EP0531529B1 (da)
KR (1) KR0181973B1 (da)
AT (1) ATE145328T1 (da)
AU (2) AU650889B2 (da)
CA (1) CA2083842A1 (da)
DE (1) DE69123248T2 (da)
DK (1) DK0531529T3 (da)
ES (1) ES2094227T3 (da)
FI (1) FI100694B (da)
NO (1) NO301215B1 (da)
RU (1) RU2098094C1 (da)
TW (1) TW207500B (da)
WO (1) WO1992017174A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284030B1 (it) * 1996-06-18 1998-05-08 Solchem Italiana Spa Metodo per la produzione di sospensioni acquose stabili, utili nelle composizioni farmaceutiche
DE69837664T2 (de) 1997-05-14 2008-01-03 Senju Pharmaceutical Co., Ltd. Wässrige suspensionspräparationen mit exzellenter redispersibilität
EP1172097B1 (en) * 1999-04-12 2004-09-08 Shionogi & Co., Ltd. Process for producing medicinal composition of a basic hydrophobic medicinal compound
CA2527712C (en) * 2003-06-13 2014-08-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI363626B (en) 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
TWI415629B (zh) 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd 含有瑞巴匹特之水性醫藥懸浮物及其製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS6143114A (ja) * 1984-08-03 1986-03-01 Takeda Chem Ind Ltd 虹彩・毛様体疾患治療用眼局所投与剤
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions

Also Published As

Publication number Publication date
TW207500B (da) 1993-06-11
EP0531529A4 (en) 1993-08-04
AU661944B2 (en) 1995-08-10
AU8104791A (en) 1992-11-02
DE69123248T2 (de) 1997-03-13
US5366985A (en) 1994-11-22
EP0531529B1 (en) 1996-11-20
FI925353A0 (fi) 1992-11-25
CA2083842A1 (en) 1992-09-28
ES2094227T3 (es) 1997-01-16
KR0181973B1 (ko) 1999-05-01
NO301215B1 (no) 1997-09-29
AU6188894A (en) 1994-06-30
NO924549L (no) 1992-11-25
AU650889B2 (en) 1994-07-07
FI925353A (fi) 1992-11-25
RU2098094C1 (ru) 1997-12-10
NO924549D0 (no) 1992-11-25
KR930700097A (ko) 1993-03-13
EP0531529A1 (en) 1993-03-17
FI100694B (fi) 1998-02-13
WO1992017174A1 (en) 1992-10-15
DE69123248D1 (de) 1997-01-02
ATE145328T1 (de) 1996-12-15

Similar Documents

Publication Publication Date Title
DE69126350T2 (de) Verfahren zur Herstellung von Chlorothiazolderivaten
DE69023934D1 (de) Substanz PF 1022, Verfahren zu ihrer Herstellung und diese Substanz enthaltende anthelmintische Zusammensetzung.
FI933391A (fi) Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning
DE69109021T2 (de) Augentropfenarzneimittel.
DK0531529T3 (da) Fremgangsmåde til fremstilling af en vandig suspension
FI911131A0 (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
NO982078D0 (no) FremgangsmÕte for beskyttelse av et donorhjerte for transplantering samt anvendelse av en N-aryl-piperazinalkanamidforbindelse for dette formÕl
RU92016488A (ru) Способ получения водной суспензии
DE59002880D1 (de) Kristalline cephem saeureadditionssalze und verfahren zu ihrer herstellung.
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
ES8506002A1 (es) Procedimiento para la obtencion de 2-(1-indolinil-metil)-imidazolinas
ES2106680B1 (es) Composiciones acuosas conteniendo ciprofloxacino y utilizacion y procedimiento correspondientes.
HU900208D0 (en) Fungicid composition comprising sulfurous acrylic acidester-derivatives as active ingredient and process for preparation thereof
HUT45016A (en) Herbicides containing as active substance derivatives of piridil-phenil-ether and process for production of these derivatives
DE58906207D1 (de) Substituierte 2-Aminothiazole.
DK486988A (da) Pyridylethanolaminer, deres fremstilling og laegemidler indeholdende forbindelserne
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
JPS6426501A (en) Growth controlling agent for sugar cane
DE69201873T2 (de) Verfahren zur Herstellung optisch aktiver Dihydropyranderivate.
AU6850090A (en) Imidazilyl propyl guanidine derivative, a process for its preparation and a pharmaceutical composition containing this compound